PB1706: ABL-CLASS GENOMIC BREAKPOINT Q-PCR FOR RELIABLE MEASURABLE RESIDUAL DISEASE MONITORING IN ALL PATIENTS

por van Outersterp, Inge, van der Velden, Vincent, Hoogeveen, Patricia, Vaitkevičienė, Goda, van Haaften, Gijs, Kuiper, Roland, Stadt, Udo Zur, Boer, Judith M., den Boer, Monique
Publicado 2023

Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all

por Kuiper, Roland P., Hoogeveen, Patricia G., Bladergroen, Reno, van Dijk, Freerk, Sonneveld, Edwin, van Leeuwen, Frank N., Boer, Judith, Sergeeva, Irina, Feitsma, Harma, den Boer, Monique L., van der Velden, Vincent H. J.
Publicado 2021

ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia

por van Outersterp, Inge, van der Velden, Vincent H.J., Hoogeveen, Patricia G., Vaitkevičienė, Goda E., Sonneveld, Edwin, van Haaften, Gijs, Kuiper, Roland P., zur Stadt, Udo, Escherich, Gabriele, Boer, Judith M., den Boer, Monique L.
Publicado 2023